The Oncolytic Effects of Bluetongue Virus(BTV) to Various Cell lines and Tumor

来源 :2013第六届世界癌症大会 | 被引量 : 0次 | 上传用户:flyinsky_zxt
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  High efficiency, specific targeting, and low-toxic treatments are now in great demand for cancer therapy.In this study, comparative analysis of differential cytopathic effects(CPEs), ultra-structural changes, viral replication and genome transcription were carried out in cancer cell lines, continuous cells(NIH3T3) and primary murine embryo fibroblast (MEF) to test BTV-16s oncolytic ability in vitro.S 180 mice tumor model was used to determine the oncogenicity potential of BTV in vivo.
其他文献
Death from cancer results primarily from the development of metastasis.We have identified MEK4 as an important therapeutic target for inhibiting expression of matrix metalloproteinase 2 (MMP2) and cel
会议
Successful establishment of metastasis by neoplasms depends on the overcoming of organ specific barriers as well as on the microenvironment dynamics on-site.It has been suggested that tumour cells in
会议
Cancer development is a complex phenomenon that involves changes in tumor physiology.These can be triggered by hypoxia that leads to oncogenic metabolism and acidosis in tumor microenviroment.Acidosis
会议
The Retinal Determination Gene Network (RDGN) is essential for the development of many organs including retinal, kidney, brain, and limb.Recently, abnormal expression of main components of RDGN (DACH1
会议
Pralatrexate was rationally designed to be a much more potent anti-folate than the widely used methotrexate.Pralatrexate was designed to have higher affinity to reduced folate carrier 1 (RFC1), to enh
会议
From 1964 on, the EORTC Lymphoma Group has conducted 9 consecutive randomised phase Ⅲ trials on early stages Hodgkin lymphoma (HL) aiming at increasing efficacy while decreasing shortand long-term tox
会议
The prognosis of patients with glioblastoma (GBM) remains poor, and the use of hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit.More recently, hypofracfionated
会议
Glioblastoma multiforme (GBM), the most common and malignant primary intracranial tumor, has a median survival of only 10 to 14 months with only 3 to 5% of patients surviving more than three years.Rec
会议
TP53 is a transcription factor that plays a pivotal role in the process of DNA repair and apoptosis.In 10-20% of patients with chronic lymphocytic leukemia (CLL), the TP53 pathway is affected by genom
会议
Glioblastoma represents the most frequent and aggressive brain tumor with a median overall survival of about 12-15 months, despite aggressive surgery and combined chemoradiotherapy.Not only is the cur
会议